Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Head and Neck Cancer

  Free Subscription


Articles published in Ann Surg

Retrieve available abstracts of 79 articles:
HTML format
Text format



Single Articles


    October 2019
  1. VAN DER WILK BJ, Noordman BJ, Neijenhuis LKA, Nieboer D, et al
    Active Surveillance Versus Immediate Surgery in Clinically Complete Responders After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Propensity Matched Study.
    Ann Surg. 2019 Oct 4. doi: 10.1097/SLA.0000000000003636.
    PubMed     Text format     Abstract available


    August 2019
  2. MARIETTE C, Markar S, Dabakuyo-Yonli TS, Meunier B, et al
    Health-related Quality of Life Following Hybrid Minimally Invasive Versus Open Esophagectomy for Patients With Esophageal Cancer, Analysis of a Multicenter, Open-label, Randomized Phase III Controlled Trial: The MIRO Trial.
    Ann Surg. 2019 Aug 9. doi: 10.1097/SLA.0000000000003559.
    PubMed     Text format     Abstract available


    July 2019
  3. SAKAMOTO T, Fujiogi M, Matsui H, Fushimi K, et al
    Comparing Perioperative Mortality and Morbidity of Minimally Invasive Esophagectomy Versus Open Esophagectomy for Esophageal Cancer: A Nationwide Retrospective Analysis.
    Ann Surg. 2019 Jul 25. doi: 10.1097/SLA.0000000000003500.
    PubMed     Text format     Abstract available


  4. URAKAWA S, Makino T, Yamasaki M, Tanaka K, et al
    Lymph Node Response to Neoadjuvant Chemotherapy as an Independent Prognostic Factor in Metastatic Esophageal Cancer.
    Ann Surg. 2019 Jul 3. doi: 10.1097/SLA.0000000000003445.
    PubMed     Text format     Abstract available


  5. SEMENKOVICH TR, Hudson JL, Subramanian M, Mullady DK, et al
    Trends in Treatment of T1N0 Esophageal Cancer.
    Ann Surg. 2019 Jul 3. doi: 10.1097/SLA.0000000000003466.
    PubMed     Text format     Abstract available


  6. SEMENKOVICH TR, Yan Y, Subramanian M, Meyers BF, et al
    A Clinical Nomogram for Predicting Node-positive Disease in Esophageal Cancer.
    Ann Surg. 2019 Jul 3. doi: 10.1097/SLA.0000000000003450.
    PubMed     Text format     Abstract available


    June 2019
  7. EYCK BM, Onstenk BD, Noordman BJ, Nieboer D, et al
    Accuracy of Detecting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Systematic Review and Meta-analysis.
    Ann Surg. 2019 Jun 7. doi: 10.1097/SLA.0000000000003397.
    PubMed     Text format     Abstract available


  8. KONCZALLA L, Ghadban T, Effenberger KE, Wostemeier A, et al
    Prospective Comparison of the Prognostic Relevance of Circulating Tumor Cells in Blood and Disseminated Tumor Cells in Bone Marrow of a Single Patient's Cohort With Esophageal Cancer.
    Ann Surg. 2019 Jun 7. doi: 10.1097/SLA.0000000000003406.
    PubMed     Text format     Abstract available


  9. LIN JX, Li P, Huang CM
    Comment on "Clinical and Prognostic Features of Patients With Esophageal Cancer and Multiple Primary Cancers".
    Ann Surg. 2019;269:e75.
    PubMed     Text format    


  10. KIYOZUMI Y, Baba Y, Okadome K, Yagi T, et al
    IDO1 Expression Is Associated With Immune Tolerance and Poor Prognosis in Patients With Surgically Resected Esophageal Cancer.
    Ann Surg. 2019;269:1101-1108.
    PubMed     Text format     Abstract available


    April 2019
  11. WEN J, Wang G, Xie X, Lin G, et al
    Prognostic Value of a Four-miRNA Signature in Patients with Lymph Node Positive Locoregional Esophageal Squamous Cell Carcinoma Undergoing Complete Surgical Resection.
    Ann Surg. 2019 Apr 30. doi: 10.1097/SLA.0000000000003369.
    PubMed     Text format     Abstract available


    March 2019
  12. YUDA M, Yamashita K, Okamura A, Hayami M, et al
    Influence of Preoperative Oropharyngeal Microflora on the Occurrence of Postoperative Pneumonia and Survival in Patients Undergoing Esophagectomy for Esophageal Cancer.
    Ann Surg. 2019 Mar 28. doi: 10.1097/SLA.0000000000003287.
    PubMed     Text format     Abstract available


  13. KOSUMI K, Baba Y, Okadome K, Yagi T, et al
    Tumor Long-interspersed Nucleotide Element-1 Methylation Level and Immune Response to Esophageal Cancer.
    Ann Surg. 2019 Mar 26. doi: 10.1097/SLA.0000000000003264.
    PubMed     Text format     Abstract available


    February 2019
  14. GOTTLIEB-VEDI E, Kauppila JH, Malietzis G, Nilsson M, et al
    Long-term Survival in Esophageal Cancer After Minimally Invasive Compared to Open Esophagectomy: A Systematic Review and Meta-analysis.
    Ann Surg. 2019 Feb 21. doi: 10.1097/SLA.0000000000003252.
    PubMed     Text format     Abstract available


    January 2019
  15. YOSHIDA N, Yamamoto H, Baba H, Miyata H, et al
    Can Minimally Invasive Esophagectomy Replace Open Esophagectomy for Esophageal Cancer? Latest Analysis of 24,233 Esophagectomies From the Japanese National Clinical Database.
    Ann Surg. 2019 Jan 31. doi: 10.1097/SLA.0000000000003222.
    PubMed     Text format     Abstract available


  16. HASHIMOTO T, Makino T, Yamasaki M, Tanaka K, et al
    The Pattern of Residual Tumor After Neoadjuvant Chemotherapy for Locally Advanced Esophageal Cancer and Its Clinical Significance.
    Ann Surg. 2019 Jan 7. doi: 10.1097/SLA.0000000000003129.
    PubMed     Text format     Abstract available


    October 2018
  17. KAUPPILA JH, Johar A, Lagergren P
    Medical and Surgical Complications and Health-related Quality of Life After Esophageal Cancer Surgery.
    Ann Surg. 2018 Oct 17. doi: 10.1097/SLA.0000000000003097.
    PubMed     Text format     Abstract available


  18. OKADOME K, Baba Y, Yagi T, Kiyozumi Y, et al
    Prognostic Nutritional Index, Tumor-infiltrating Lymphocytes, and Prognosis in Patients with Esophageal Cancer.
    Ann Surg. 2018 Oct 10. doi: 10.1097/SLA.0000000000002985.
    PubMed     Text format     Abstract available


  19. VAN DER SLUIS PC, van der Horst S, May AM, Schippers C, et al
    Robot-assisted Minimally Invasive Thoracolaparoscopic Esophagectomy Versus Open Transthoracic Esophagectomy for Resectable Esophageal Cancer: A Randomized Controlled Trial.
    Ann Surg. 2018 Oct 10. doi: 10.1097/SLA.0000000000003031.
    PubMed     Text format     Abstract available


    July 2018
  20. MARKAR SR, Arhi C, Leusink A, Vidal-Diez A, et al
    The Influence of Antireflux Surgery on Esophageal Cancer Risk in England: National Population-based Cohort Study.
    Ann Surg. 2018 Jul 24. doi: 10.1097/SLA.0000000000002890.
    PubMed     Text format     Abstract available


  21. O'NEILL LM, Guinan E, Doyle SL, Bennett AE, et al
    The RESTORE Randomized Controlled Trial: Impact of a Multidisciplinary Rehabilitative Program on Cardiorespiratory Fitness in Esophagogastric cancer Survivorship.
    Ann Surg. 2018 Jul 12. doi: 10.1097/SLA.0000000000002895.
    PubMed     Text format     Abstract available


  22. KAUPPILA JH, Johar A, Lagergren P
    Postoperative Complications and Health-related Quality of Life 10 Years After Esophageal Cancer Surgery.
    Ann Surg. 2018 Jul 10. doi: 10.1097/SLA.0000000000002972.
    PubMed     Text format     Abstract available


  23. YOSHIDA N, Kosumi K, Tokunaga R, Baba Y, et al
    Clinical Importance of Mean Corpuscular Volume as a Prognostic Marker After Esophagectomy for Esophageal Cancer: A Retrospective Study.
    Ann Surg. 2018 Jul 10. doi: 10.1097/SLA.0000000000002971.
    PubMed     Text format     Abstract available


    June 2018
  24. MARKAR SR, Lagergren J
    Response "Surgeon Age in Relation to Prognosis After Esophageal Cancer Resection".
    Ann Surg. 2018 Jun 1. doi: 10.1097/SLA.0000000000002841.
    PubMed     Text format    


    May 2018
  25. LU J, Xie JW, Cao LL, Zheng CH, et al
    Surgeon Age in Relation to Prognosis After Esophageal Cancer Resection.
    Ann Surg. 2018 May 23. doi: 10.1097/SLA.0000000000002835.
    PubMed     Text format    


  26. LIN JX, Li P, Huang CM
    Clinical and Prognostic Features of Patients With Esophageal Cancer and Multiple Primary Cancers.
    Ann Surg. 2018 May 23. doi: 10.1097/SLA.0000000000002833.
    PubMed     Text format    


  27. VISSER E, Markar SR, Ruurda JP, Hanna GB, et al
    Prognostic Value of Lymph Node Yield on Overall Survival in Esophageal Cancer Patients: A Systematic Review and Meta-analysis.
    Ann Surg. 2018 May 23. doi: 10.1097/SLA.0000000000002824.
    PubMed     Text format     Abstract available


  28. MAKINO T, Yamasaki M, Tanaka K, Masuike Y, et al
    Metabolic Tumor Volume Change Predicts Long-term Survival and Histological Response to Preoperative Chemotherapy in Locally Advanced Esophageal Cancer.
    Ann Surg. 2018 May 1. doi: 10.1097/SLA.0000000000002808.
    PubMed     Text format     Abstract available


    April 2018
  29. STURM EC, Zahnd WE, Mellinger JD, Ganai S, et al
    Survival Implications of Increased Utilization of Local Excision for cT1N0 Esophageal Cancer.
    Ann Surg. 2018 Apr 18. doi: 10.1097/SLA.0000000000002782.
    PubMed     Text format     Abstract available


  30. ADAM MA, Thomas S, Youngwirth L, Hyslop T, et al
    Reply to: "Surgeon Volume Threshold for Total Thyroidectomy".
    Ann Surg. 2018;267:e78-e79.
    PubMed     Text format    


  31. AVERY KNL, Chalmers KA, Brookes ST, Blencowe NS, et al
    Development of a Core Outcome Set for Clinical Effectiveness Trials in Esophageal Cancer Resection Surgery.
    Ann Surg. 2018;267:700-710.
    PubMed     Text format     Abstract available


  32. BROWN CS, Lapin B, Goldstein JL, Linn JG, et al
    Predicting Progression in Barrett's Esophagus: Development and Validation of the Barrett's Esophagus Assessment of Risk Score (BEAR Score).
    Ann Surg. 2018;267:716-720.
    PubMed     Text format     Abstract available


    March 2018
  33. KIYOZUMI Y, Baba Y, Okadome K, Yagi T, et al
    IDO1 Expression Is Associated With Immune Tolerance and Poor Prognosis in Patients With Surgically Resected Esophageal Cancer.
    Ann Surg. 2018 Mar 27. doi: 10.1097/SLA.0000000000002754.
    PubMed     Text format     Abstract available


  34. SUN HB, Li Y, Liu XB, Zhang RX, et al
    Early Oral Feeding Following McKeown Minimally Invasive Esophagectomy: An Open-label, Randomized, Controlled, Noninferiority Trial.
    Ann Surg. 2018;267:435-442.
    PubMed     Text format     Abstract available


  35. WORRELL SG, Alicuben ET, Oh DS, Hagen JA, et al
    Accuracy of Clinical Staging and Outcome With Primary Resection for Local-Regionally Limited Esophageal Adenocarcinoma.
    Ann Surg. 2018;267:484-488.
    PubMed     Text format     Abstract available


  36. BABA Y, Yoshida N, Kinoshita K, Iwatsuki M, et al
    Clinical and Prognostic Features of Patients With Esophageal Cancer and Multiple Primary Cancers: A Retrospective Single-institution Study.
    Ann Surg. 2018;267:478-483.
    PubMed     Text format     Abstract available


    February 2018
  37. LEE SH, Roh JL, Gong G, Cho KJ, et al
    Risk Factors for Recurrence After Treatment of N1b Papillary Thyroid Carcinoma.
    Ann Surg. 2018 Feb 16. doi: 10.1097/SLA.0000000000002710.
    PubMed     Text format     Abstract available


  38. LOWENFELS AB, Maisonneuve P
    Esophageal Cancer: Long-term Survival and Day of Surgery.
    Ann Surg. 2018;267:e26.
    PubMed     Text format    


  39. LAGERGREN J, Mattsson F, Lagergren P
    Reply to Letter: "Esophageal Cancer: Long-term Survival and Day of Surgery".
    Ann Surg. 2018;267:e26-e27.
    PubMed     Text format    


  40. VAN PUTTEN M, Koeter M, van Laarhoven HWM, Lemmens VEPP, et al
    Hospital of Diagnosis Influences the Probability of Receiving Curative Treatment for Esophageal Cancer.
    Ann Surg. 2018;267:303-310.
    PubMed     Text format     Abstract available


    January 2018
  41. XI M, Yang Y, Zhang L, Yang H, et al
    Multi-institutional Analysis of Recurrence and Survival After Neoadjuvant Chemoradiotherapy of Esophageal Cancer: Impact of Histology on Recurrence Patterns and Outcomes.
    Ann Surg. 2018 Jan 12. doi: 10.1097/SLA.0000000000002670.
    PubMed     Text format     Abstract available


  42. PHILLIPS AW, Dent B, Navidi M, Immanuel A, et al
    Trainee Involvement in Ivor Lewis Esophagectomy Does Not Negatively Impact Outcomes.
    Ann Surg. 2018;267:94-98.
    PubMed     Text format     Abstract available


    December 2017
  43. SONOHARA F, Gao F, Iwata N, Kanda M, et al
    Genome-wide Discovery of a Novel Gene-expression Signature for the Identification of Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma.
    Ann Surg. 2017 Dec 12. doi: 10.1097/SLA.0000000000002622.
    PubMed     Text format     Abstract available


  44. YAGI T, Baba Y, Ishimoto T, Iwatsuki M, et al
    PD-L1 Expression, Tumor-infiltrating Lymphocytes, and Clinical Outcome in Patients With Surgically Resected Esophageal Cancer.
    Ann Surg. 2017 Dec 4. doi: 10.1097/SLA.0000000000002616.
    PubMed     Text format     Abstract available


  45. ROBB WB, Maillard E, Mariette C
    Lymph Node Status After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: Implications for the Extent of Lymphadenectomy.
    Ann Surg. 2017;266:e53-e54.
    PubMed     Text format    


  46. TALSMA K, Wijnhoven B, van Lanschot J, van Berge Henegouwen M, et al
    Impact of Neoadjuvant Chemoradiation on Lymph Node Status in Esophageal Cancer: Post hoc Analysis of a Randomized Controlled Trial.
    Ann Surg. 2017;266:e52-e53.
    PubMed     Text format    


  47. ZHANG YQ, Chen T, Zhang C, Li QL, et al
    Endoscopic Submucosal Dissection for Superficial Proximal Esophageal Neoplasia is Highly Successful.
    Ann Surg. 2017;266:995-999.
    PubMed     Text format     Abstract available


  48. HOANG D, Broer N, Sosa JA, Abitbol N, et al
    Leptin Is Produced by Parathyroid Glands and Stimulates Parathyroid Hormone Secretion.
    Ann Surg. 2017;266:1075-1083.
    PubMed     Text format     Abstract available


  49. SCHNEIDER A, Michaud L, Gottrand F
    Prevalence of Barrett Esophagus in Adolescents and Young Adults With Esophageal Atresia.
    Ann Surg. 2017;266:e96.
    PubMed     Text format    


  50. VERGOUWE FWT, Wijnen RMH, Bruno MJ, Spaander MCW, et al
    Prevalence of Barrett Esophagus in Adolescents and Young Adults With Esophageal Atresia.
    Ann Surg. 2017;266:e95-e96.
    PubMed     Text format    


    November 2017
  51. SEESING MFJ, Gisbertz SS, Goense L, van Hillegersberg R, et al
    A Propensity Score Matched Analysis of Open Versus Minimally Invasive Transthoracic Esophagectomy in the Netherlands.
    Ann Surg. 2017;266:839-846.
    PubMed     Text format     Abstract available


  52. VISSER E, Rossum PSNV, Ruurda JP, Hillegersberg RV, et al
    Impact of Lymph Node Yield on Overall Survival in Patients Treated With Neoadjuvant Chemoradiotherapy Followed by Esophagectomy for Cancer: A Population-based Cohort Study in the Netherlands.
    Ann Surg. 2017;266:863-869.
    PubMed     Text format     Abstract available


    August 2017
  53. ELLIOTT JA, Doyle SL, Murphy CF, King S, et al
    Sarcopenia: Prevalence, and Impact on Operative and Oncologic Outcomes in the Multimodal Management of Locally Advanced Esophageal Cancer.
    Ann Surg. 2017 Aug 8. doi: 10.1097/SLA.0000000000002398.
    PubMed     Text format     Abstract available


  54. GRAJEK M, Maciejewski A, Giebel S, Krakowczyk L, et al
    First Complex Allotransplantation of Neck Organs: Larynx, Trachea, Pharynx, Esophagus, Thyroid, Parathyroid Glands, and Anterior Cervical Wall: A Case Report.
    Ann Surg. 2017;266:e19-e24.
    PubMed     Text format     Abstract available


  55. STRAATMAN J, van der Wielen N, Cuesta MA, Daams F, et al
    Minimally Invasive Versus Open Esophageal Resection: Three-year Follow-up of the Previously Reported Randomized Controlled Trial: the TIME Trial.
    Ann Surg. 2017;266:232-236.
    PubMed     Text format     Abstract available


    July 2017
  56. MANTZIARI S, Gronnier C, Renaud F, Duhamel A, et al
    Survival Benefit of Neoadjuvant Treatment in Clinical T3N0M0 Esophageal Cancer: Results From a Retrospective Multicenter European Study.
    Ann Surg. 2017 Jul 24. doi: 10.1097/SLA.0000000000002402.
    PubMed     Text format     Abstract available


  57. DEGISORS S, Pasquer A, Renaud F, Behal H, et al
    Are Thoracotomy and/or Intrathoracic Anastomosis Still Predictors of Postoperative Mortality After Esophageal Cancer Surgery?: A Nationwide Study.
    Ann Surg. 2017 Jul 24. doi: 10.1097/SLA.0000000000002401.
    PubMed     Text format     Abstract available


  58. STEFFEN T, Dietrich D, Schnider A, Kettelhack C, et al
    Recurrence Patterns and Long-Term Results After Induction Chemotherapy, Chemoradiotherapy, and Curative Surgery in Patients With Locally Advanced Esophageal Cancer.
    Ann Surg. 2017 Jul 24. doi: 10.1097/SLA.0000000000002435.
    PubMed     Text format     Abstract available


  59. MARKAR SR, Mackenzie H, Askari A, Faiz O, et al
    Effect of Esophageal Cancer Surgeon Volume on Management and Mortality From Emergency Upper Gastrointestinal Conditions: Population-based Cohort Study.
    Ann Surg. 2017 Jul 12. doi: 10.1097/SLA.0000000000002387.
    PubMed     Text format     Abstract available


  60. MORIS D, Dimitroulis D
    The Comparison of Surgical Approaches in Locally Advanced Esophageal Cancer: Significant Insights but Clinical Fidelity Still to Be Delivered.
    Ann Surg. 2017;266:e11-e12.
    PubMed     Text format    


  61. VISSER E, van Rossum PSN, Verhoeven RHA, Ruurda JP, et al
    Impact of Weekday of Esophagectomy on Short-term and Long-term Oncological Outcomes: A Nationwide Population-based Cohort Study in the Netherlands.
    Ann Surg. 2017;266:76-81.
    PubMed     Text format     Abstract available


  62. ZAIDI AH, Kosovec JE, Matsui D, Omstead AN, et al
    PI3K/mTOR Dual Inhibitor, LY3023414, Demonstrates Potent Antitumor Efficacy Against Esophageal Adenocarcinoma in a Rat Model.
    Ann Surg. 2017;266:91-98.
    PubMed     Text format     Abstract available


  63. ELLIOTT JA, Docherty NG, Eckhardt HG, Doyle SL, et al
    Weight Loss, Satiety, and the Postprandial Gut Hormone Response After Esophagectomy: A Prospective Study.
    Ann Surg. 2017;266:82-90.
    PubMed     Text format     Abstract available


    June 2017
  64. BARBOUR AP, Cormack OMM, Baker PJ, Hirst J, et al
    Long-term Health-related Quality of Life Following Esophagectomy: A Nonrandomized Comparison of Thoracoscopically Assisted and Open Surgery.
    Ann Surg. 2017;265:1158-1165.
    PubMed     Text format     Abstract available


  65. WONG AT, Shao M, Rineer J, Lee A, et al
    The Impact of Adjuvant Postoperative Radiation Therapy and Chemotherapy on Survival After Esophagectomy for Esophageal Carcinoma.
    Ann Surg. 2017;265:1146-1151.
    PubMed     Text format     Abstract available


  66. WILSON MZ, Enomoto LM, Messaris E, Hollenbeak CS, et al
    Misapplication of Statistical Methods May Lead to Misinformation.
    Ann Surg. 2017;265:E78-E79.
    PubMed     Text format    


    May 2017
  67. ROBB WB, Mariette C
    Reply to Letter: "Tumor Response and Lymph Node Status After Neoadjuvant Chemoradiotherapy for Esophageal Cancer".
    Ann Surg. 2017;265:e69-e70.
    PubMed     Text format    


  68. ECKER BL, Dempsey DT
    In Response to "Impact of Neoadjuvant Chemoradiation on Lymph Node Status in Esophageal Cancer".
    Ann Surg. 2017;265:e69.
    PubMed     Text format    


    April 2017
  69. LI B, Hu H, Zhang Y, Zhang J, et al
    Extended Right Thoracic Approach Compared With Limited Left Thoracic Approach for Patients With Middle and Lower Esophageal Squamous Cell Carcinoma: Three-year Survival of a Prospective, Randomized, Open-label Trial.
    Ann Surg. 2017 Apr 26. doi: 10.1097/SLA.0000000000002280.
    PubMed     Text format     Abstract available


  70. NAKASHIMA Y, Saeki H, Nakanishi R, Sugiyama M, et al
    Assessment of Sarcopenia as a Predictor of Poor Outcomes After Esophagectomy in Elderly Patients With Esophageal Cancer.
    Ann Surg. 2017 Apr 21. doi: 10.1097/SLA.0000000000002252.
    PubMed     Text format     Abstract available


  71. MARKAR SR, Mackenzie H, Lagergren P, Lagergren J, et al
    Surgeon Age in Relation to Prognosis After Esophageal Cancer Resection.
    Ann Surg. 2017 Apr 7. doi: 10.1097/SLA.0000000000002260.
    PubMed     Text format     Abstract available


  72. PHILLIPS AW, Lagarde SM, Navidi M, Disep B, et al
    Impact of Extent of Lymphadenectomy on Survival, Post Neoadjuvant Chemotherapy and Transthoracic Esophagectomy.
    Ann Surg. 2017;265:750-756.
    PubMed     Text format     Abstract available


  73. BANSAL N, Mayilvaganan S
    Primary Hyperparathyroidism With Negative Imaging: A Significant Clinical Problem.
    Ann Surg. 2017;265:e41.
    PubMed     Text format    


    March 2017
  74. MARKAR SR, Mackenzie H, Jemal S, Faiz O, et al
    Emergency Presentation of Esophagogastric Cancer: Predictors and Long-term Prognosis.
    Ann Surg. 2017 Mar 20. doi: 10.1097/SLA.0000000000002224.
    PubMed     Text format     Abstract available


  75. PASQUALI S, Yim G, Vohra RS, Mocellin S, et al
    Survival After Neoadjuvant and Adjuvant Treatments Compared to Surgery Alone for Resectable Esophageal Carcinoma: A Network Meta-analysis.
    Ann Surg. 2017;265:481-491.
    PubMed     Text format     Abstract available


    February 2017
  76. CHEN T, Zhou PH, Chu Y, Zhang YQ, et al
    Long-term Outcomes of Submucosal Tunneling Endoscopic Resection for Upper Gastrointestinal Submucosal Tumors.
    Ann Surg. 2017;265:363-369.
    PubMed     Text format     Abstract available


  77. SHAPIRO J, Biermann K, van Klaveren D, Offerhaus GJ, et al
    Prognostic Value of Pretreatment Pathological Tumor Extent in Patients Treated With Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal or Junctional Cancer.
    Ann Surg. 2017;265:356-362.
    PubMed     Text format     Abstract available


  78. VAN OLPHEN SH, Biermann K, Shapiro J, Wijnhoven BP, et al
    P53 and SOX2 Protein Expression Predicts Esophageal Adenocarcinoma in Response to Neoadjuvant Chemoradiotherapy.
    Ann Surg. 2017;265:347-355.
    PubMed     Text format     Abstract available


    July 2016
  79. PASQUER A, Renaud F, Hec F, Gandon A, et al
    Is Centralization Needed for Esophageal and Gastric Cancer Patients With Low Operative Risk?: A Nationwide Study.
    Ann Surg. 2016.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: